Recently, investigators have shown that circHIAT1 functions as a metastatic inhibitor to suppress androgen receptor (AR)-enhanced RCC cell migration and invasion and that targeting AR could suppress RCC cell progression via increasing circHIAT1 expression (Wang et al., 2017). This evidence concerns the gene AR and renal cell carcinoma.